Crossref
PRO: Systemic Therapy for All Endometrial Cancers Should be Paclitaxel Plus Carboplatin
Clinical Ovarian Cancer · 2011
DOI: 10.1016/j.cloc.2012.02.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von Matthew A. Powell. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Powell, M. A. (2011). PRO: Systemic Therapy for All Endometrial Cancers Should be Paclitaxel Plus Carboplatin. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2012.02.016
Vancouver
Powell MA. PRO: Systemic Therapy for All Endometrial Cancers Should be Paclitaxel Plus Carboplatin. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2012.02.016
BibTeX
@article{Powell2011,
author = {Powell, Matthew A.},
title = {PRO: Systemic Therapy for All Endometrial Cancers Should be Paclitaxel Plus Carboplatin},
journal = {Clinical Ovarian Cancer},
year = {2011},
doi = {10.1016/j.cloc.2012.02.016}
}
EUVIMED